Actualités

2025

Publications et brevets

A. Roche et al Development of an ophthalmic solution combining allogenic plasma with protective excipients for enhanced therapeutic role in the management of ocular surface diseases, European Journal of Pharmaceutics and Bipharmaceutics, 2025, Sep, 214:114813. doi: 10.1016/j.ejpb.2025.114813.

Claves. J et al. Physical stability of bevacizumab solutions for intravitreal injections: Influence of conditioning material and storage conditions. International Journal of Pharmaceutics, 2025, Apr 15;674:125453. doi: 10.1016/j.ijpharm.2025.125453

Communications orales

N/R

Communications affichées

N/R